Aug. 15 at 8:16 PM
$MBOT An interesting search result re. Corpath:
When Siemens Healthineers agreed to acquire Corindus Vascular Robotics (the maker of the CorPath system) for
$1.1 billion in August 2019, Corindus was generating approximately
$12.3 million in revenue on a trailing 12-month basis. For its second quarter of 2019, the company reported quarterly revenue of
$4.6 million.
A measly
$12.3M in revs commanded a
$1.1B acquisition. Point is Corindus didn’t have to reach multiple 10’s or 100’s of millions in sales to get taken out.
IMO all Microbot needs to do is show that hospital (systems) have growing and recurring appetite for LIBERTY. A very low bar of actual revenue will be required for acquisition, once some stickiness is shown within even a limited number of systems.
Just sayin’.
